Karuna Therapeutics, Inc. (KRTX) News

Karuna Therapeutics, Inc. (KRTX): $329.83

0.09 (+0.03%)

POWR Rating

Component Grades








Add KRTX to Watchlist
Sign Up

Industry: Biotech




#314 of 342

in industry

Filter KRTX News Items

KRTX News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

KRTX News Highlights

  • KRTX's 30 day story count now stands at 21.
  • Over the past 7 days, the trend for KRTX's stories per day has been choppy and unclear. It has oscillated between 1 and 13.
  • BMY, DRUG and DOW are the most mentioned tickers in articles about KRTX.

Latest KRTX News From Around the Web

Below are the latest news stories about KARUNA THERAPEUTICS INC that investors may wish to consider to help them evaluate KRTX as an investment opportunity.

Biotech Stock Roundup: BMY's KRTX and RYZB Acquisition, CYTK Surges on Study Data

Bristol Myers (BMY) and Cytokinetics (CYTK) are in the news on acquisition announcements and study updates, respectively.

Yahoo | December 28, 2023

Bristol Myers (BMY) to Buy Cancer Drug-Maker RayzeBio for $4.1B

Bristol Myers (BMY) is set to acquire RayzeBio for $4.1 billion to strengthen and diversify its already established oncology portfolio. The transaction is expected to close in the first half of 2024.

Yahoo | December 27, 2023

Trending tickers: Intel | Tencent | RayzeBio | Astrazeneca

The latest investor updates on stocks that are trending on Wednesday.

Yahoo | December 27, 2023

Why Is RayzeBio (RYZB) Stock Up 100% Today?

RYZB stock has doubled today after Bristol Myers Squibb shelled out $4.1 billion to buy RayzeBio.

Dana Blankenhorn on InvestorPlace | December 26, 2023

Bristol Myers buying RayzeBio, FedEx buyback: Trending tickers

FedEx (FDX) shares rose after the shipping giant announced a $1 billion accelerated share buyback plan. Shares of RayzeBio (RYZB) jumped 100% after it was announced the company was being acquired by Bristol Myers Squibb (BMY) in a $4.1 billion deal. It's Bristol Myers' second deal in less than a week. On Friday, the company announced it was acquiring Karuna Therapeutics (KRTX) in a $14 billion deal. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.

Yahoo | December 26, 2023

Karuna (KRTX) Up 48% on $14B Buyout Offer From Bristol Myers

Bristol Myers (BMY) is set to acquire Karuna (KRTX) for $330 per share. This transaction is expected to close in the first half of 2024.

Yahoo | December 26, 2023

Karuna downgraded, Arm target raised: Wall Street's top analyst calls

Karuna downgraded, Arm target raised: Wall Street's top analyst calls

Yahoo | December 26, 2023

3 Charts For Investors to Watch Tuesday: Bitcoin, Oil, XBI ETF

These 3 charts are worth watching on Tuesday. We look at the reasons why and identify important technical levels to watch.

Yahoo | December 26, 2023

Stock Market Closes Mixed But Indexes Post Weekly Gains; The Dow Got Coal Today

The stock market major indexes closed mixed on Friday ahead of the long weekend. Chinese gaming stocks sold off while biotech stocks rallied.

Yahoo | December 22, 2023

Bristol's $14 Billion Takeover Of Karuna Pulled A Bevy Of Stocks Higher

Bristol Myers Squibb announced its $14 billion acquisition of Karuna Therapeutics on Friday, sending KRTX stock into the stratosphere.

Yahoo | December 22, 2023

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!